U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1994
149
Substance Class Polymer
Created
by admin
on Sat Dec 16 18:08:44 GMT 2023
Edited
by admin
on Sat Dec 16 18:08:44 GMT 2023
Record UNII
7194H8W3KT
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
ALTERNATIVE DEFINITION for [SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN]
Alternative Definition
Name Type Language
SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
Common Name English
SALMONELLA TYPHI TY2 POLYSACCHARIDE ANTIGEN, A
Common Name English
SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
Common Name English
Classification Tree Code System Code
NDF-RT N0000183910
Created by admin on Sat Dec 16 18:08:45 GMT 2023 , Edited by admin on Sat Dec 16 18:08:45 GMT 2023
NDF-RT N0000183901
Created by admin on Sat Dec 16 18:08:45 GMT 2023 , Edited by admin on Sat Dec 16 18:08:45 GMT 2023
NCI_THESAURUS C75819
Created by admin on Sat Dec 16 18:08:45 GMT 2023 , Edited by admin on Sat Dec 16 18:08:45 GMT 2023
Code System Code Type Description
NDF-RT
N0000178997
Created by admin on Sat Dec 16 18:08:45 GMT 2023 , Edited by admin on Sat Dec 16 18:08:45 GMT 2023
PRIMARY Vaccines, Typhoid [Chemical/Ingredient]
DAILYMED
7194H8W3KT
Created by admin on Sat Dec 16 18:08:45 GMT 2023 , Edited by admin on Sat Dec 16 18:08:45 GMT 2023
PRIMARY
NDF-RT
N0000179280
Created by admin on Sat Dec 16 18:08:45 GMT 2023 , Edited by admin on Sat Dec 16 18:08:45 GMT 2023
PRIMARY Vi polysaccharide vaccine, typhoid [Chemical/Ingredient]
EVMPD
SUB12387MIG
Created by admin on Sat Dec 16 18:08:45 GMT 2023 , Edited by admin on Sat Dec 16 18:08:45 GMT 2023
ALTERNATIVE
NDF-RT
N0000183364
Created by admin on Sat Dec 16 18:08:45 GMT 2023 , Edited by admin on Sat Dec 16 18:08:45 GMT 2023
PRIMARY Actively Acquired Immunity [PE]
EVMPD
SUB12386MIG
Created by admin on Sat Dec 16 18:08:45 GMT 2023 , Edited by admin on Sat Dec 16 18:08:45 GMT 2023
ALTERNATIVE
FDA UNII
7194H8W3KT
Created by admin on Sat Dec 16 18:08:45 GMT 2023 , Edited by admin on Sat Dec 16 18:08:45 GMT 2023
PRIMARY
NDF-RT
N0000170916
Created by admin on Sat Dec 16 18:08:45 GMT 2023 , Edited by admin on Sat Dec 16 18:08:45 GMT 2023
PRIMARY Vaccines, Inactivated [Chemical/Ingredient]
NCI_THESAURUS
C77765
Created by admin on Sat Dec 16 18:08:45 GMT 2023 , Edited by admin on Sat Dec 16 18:08:45 GMT 2023
PRIMARY
EVMPD
SUB12385MIG
Created by admin on Sat Dec 16 18:08:45 GMT 2023 , Edited by admin on Sat Dec 16 18:08:45 GMT 2023
PRIMARY
RXCUI
807219
Created by admin on Sat Dec 16 18:08:45 GMT 2023 , Edited by admin on Sat Dec 16 18:08:45 GMT 2023
PRIMARY RxNorm
Display Structure of SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
Related Record Type Details
TYPHOID VI POLYSACCHARIDE VACCINE
SUB_CONCEPT->SUBSTANCE
SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI
TARGET ORGANISM->VACCINE ANTIGEN
Related Record Type Details
SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
DEACYLATION 3-O-DEACYLATION Amount: UNSPECIFIED SUBSTANCE
76601573
(not in database)
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:WEIGHT AVERAGE CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966